Reach Us +1-504-608-2390
Biochemical Markers of In Vivo Hepatotoxicity | OMICS International | Abstract
ISSN: 2161-0495

Journal of Clinical Toxicology
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article

Biochemical Markers of In Vivo Hepatotoxicity

Arika WM*, Nyamai DW, Osano KO, Ngugi MP, and Njagi ENM

Department of Biochemistry and Biotechnology, School of Pure and Applied Sciences, Kenyatta University, Kenya

*Corresponding Author:
Arika WM
Department of Biochemistry and Biotechnology
Kenyatta University
P.O. Box 43844-00100, Nairobi, Kenya
Tel: +254722863595/+254722873150
E-mail: [email protected]

Received date: February 29, 2016; Accepted date: April 13, 2016; Published date: April 20, 2016

Citation: Arika WM, Nyamai DW, Osano KO, Ngugi MP, Njagi ENM (2016) Biochemical Markers of In Vivo Hepatotoxicity. J Clin Toxicol 6:297. doi: 10.4172/2161-0495.1000297

Copyright: © 2016 Arika WM, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


A chemical compound, whether of natural or of synthetic origin, brings about a toxicological effect when its dose is high enough or the duration of exposure is sufficient to cause an alteration in the normal homeostasis of body fluids and tissues. Therefore, the right dose differentiates a toxicant from a remedy. The body detoxifies drugs and other chemical compounds through key organs such as the liver. The liver plays a central role in the metabolism and excretion of xenobiotics which makes it highly susceptible to their adverse and toxic effects. These effects can be manifested in the form of hepatic injuries, which take many forms from cellular degeneration and necrosis to cirrhosis or cholestasis to vascular injury. Exposure to hepatotoxicants alters the homeostatic balance of various biological markers that provides a powerful and dynamic approach to understanding the spectrum of liver diseases. These markers offer a means for homogeneous classification of a disease and risk factor, and they can extend one's basic information about the underlying pathogenesis of disease and in drug design.